Latest Articles
- Interpreting the COMET trial
Although survival was better with carvedilol than with immediate-release metoprolol tartrate, we must increase the use of any approved beta-blocker in heart failure.
Endovascular therapy or conventional vascular surgery? A complex choiceAortic aneurysms, carotid stenosis, peripheral vascular disease, and stenosis of visceral vessels can now be treated percutaneously, but less invasive isn’t always better.
- Atrial fibrillation (June 2003)
Rate control vs rhythm control in atrial fibrillation (Cleve Clin J Med 2003; 70:567–573).
- Talking to patients about St. John’s wort
St. John’s wort, an unregulated herbal supplement widely used as a self-treatment for depression, can cause side effects and drug interactions.
- Scleroderma: A treatable disease
Scleroderma can be effectively treated in many cases now, thanks to a better understanding of its pathogenesis and new therapies.
- The Heart Protection Study: High-risk patients benefit from statins, regardless of LDL-C level
Nearly all patients at high risk of a coronary event should be taking a statin drug, regardless of their low-density lipoprotein level. We explain the rationale, design, findings, and implications of this important study.
- Alcohol and health: A drink a day won’t keep the doctor away
Do not advise patients to start drinking alcohol for its alleged cardiovascular benefits.
